Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Cochlear Limited (CHEOF – Research Report), Verve Therapeutics (VERV – Research Report) and Allogene Therapeutics (ALLO – Research Report).
Cochlear Limited (CHEOF)
Macquarie analyst Macquarie maintained a Hold rating on Cochlear Limited yesterday and set a price target of A$197.00. The company’s shares closed last Friday at $154.93.
The word on The Street in general, suggests a Hold analyst consensus rating for Cochlear Limited with a $150.53 average price target, implying a -2.8% downside from current levels. In a report released yesterday, Citigroup also downgraded the stock to Hold with a A$225.00 price target.
See Insiders’ Hot Stocks on TipRanks >>
Verve Therapeutics (VERV)
LifeSci Capital analyst Patrick Dolezal maintained a Buy rating on Verve Therapeutics on August 10 and set a price target of $50.00. The company’s shares closed last Friday at $33.48.
According to TipRanks.com, Dolezal has 0 stars on 0-5 stars ranking scale with an average return of
Currently, the analyst consensus on Verve Therapeutics is a Moderate Buy with an average price target of $49.50, which is a 42.4% upside from current levels. In a report issued on August 9, RBC Capital also maintained a Buy rating on the stock with a $42.00 price target.
Allogene Therapeutics (ALLO)
William Blair analyst Raju Prasad maintained a Buy rating on Allogene Therapeutics on August 9. The company’s shares closed last Friday at $14.81.
According to TipRanks.com, Prasad is a 1-star analyst with an average return of
Allogene Therapeutics has an analyst consensus of Moderate Buy, with a price target consensus of $28.00, implying an 86.4% upside from current levels. In a report issued on August 10, JMP Securities also reiterated a Buy rating on the stock with a $23.00 price target.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Read More on CHEOF:
